ARDX

7 insiders, sell · $476K · Grade B

Integrated Core Strategies (US) LLC — 13G/A, 4.8% of Ardelyx, Inc.

Ardelyx — A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Ardelyx — Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

7 insiders, sell · $532K · Grade B

JANUS HENDERSON GROUP PLC — 13G/A, 3.4% of ARDELYX, INC.

STATE STREET CORPORATION — 13G, 5.5% of ARDELYX INC

Integrated Core Strategies (US) LLC — 13G/A, 7.2% of Ardelyx, Inc.

The Vanguard Group — 13G/A, 0% of Ardelyx Inc

8 insiders, mixed · $2.4M · Grade A

The Vanguard Group — 13G/A, 7.81% of Ardelyx Inc

Integrated Core Strategies (US) LLC — 13G, 5.3% of Ardelyx, Inc.

6 insiders, sell · $453K · Grade B

JANUS HENDERSON GROUP PLC — 13G/A, 5.7% of ARDELYX, INC.

Millennium Management LLC — 13G/A, 3.2% of Ardelyx, Inc.

6 insiders, sell · $691K · Grade C

JANUS HENDERSON GROUP PLC — 13G/A, 6.3% of ARDELYX, INC.